Trade Ideas

Actionable trade ideas with defined risk and time horizons.

Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.

Articles

14,465 total articles

Contemporary Amperex Technology - A Measured Long to Test the Bear Case

Contemporary Amperex Technology - A Measured Long to Test the Bear Case

CATL faces a clear bear narrative - slowing EV demand, margin pressure, and rising competition. That narrative is priced into the stock enough to justify a tactical, risk-managed long. Entry $60.00, stop $52.00, target $78.00. Trade horizon: mixed - initial check at mid-term (45 trading days), full thesis plays out over long term (180 trading days)…

Zoetis: Selling Panic Has Left Value on the Table

Zoetis: Selling Panic Has Left Value on the Table

Zoetis shares have been hammered this year amid disappointing Companion Animal trends and a flurry of securities lawsuits. The market has re-priced the stock to roughly $30 billion in market cap, trading near its 52-week low. With a P/E around 11.5, solid free cash flow of $2.37B, and positive structural tailwinds in animal health diagnostics, the …

Buy the Dip: Accenture’s AI-Led Rebound Still Has Room to Run

Buy the Dip: Accenture’s AI-Led Rebound Still Has Room to Run

Accenture (ACN) is trading well below its 52-week high but still shows the structural earnings quality and cash generation to support a bounce. With free cash flow north of $12.5B, a modest net-debt profile, and AI bookings accelerating, the risk/reward favors a tactical long over the next several weeks if the stock clears near-term technical resis…

Microsoft's Moat: Why Distribution Still Beats Chasing the Next Model

Microsoft's Moat: Why Distribution Still Beats Chasing the Next Model

Microsoft's edge is not just the next generative model; it's the unrivaled distribution of Azure, Office, Windows and LinkedIn into enterprise workflows. At current levels we view a measured long trade as attractive: valuation is rich but supported by $67B free cash flow, a 30% ROE and a massive $3.66T market cap. Trade plan and risk controls below…

Nano Labs (NA) - Buy Before the AI/BNB Catalysts

Nano Labs (NA) - Buy Before the AI/BNB Catalysts

Nano Labs (NA) trades at $2.25 and a market cap of about $52.2M. The company is pivoting from pure fabless chip design toward AI hardware and Web3 convergence, backed by a strategic crypto reserve (70,000 BNB) and a MoU to explore North American AI data centers. Recent H1 2026 results show severe near-term headwinds, but the stock’s valuation alrea…

Lucid’s Bolt Deal: A Catalyst Worth a Speculative Mid-Term Long?

Lucid’s Bolt Deal: A Catalyst Worth a Speculative Mid-Term Long?

Lucid’s recent Bolt-related deal (terms thinly reported) creates a near-term narrative catalyst that could re-rate the stock if it meaningfully improves volumes, margins or battery scale. The company still carries a stretched balance sheet, negative profitability and steep recent share-price underperformance; this idea is a speculative mid-term lon…

SK hynix: Memory Supercycle Has Room to Run - Tactical Long

SK hynix: Memory Supercycle Has Room to Run - Tactical Long

SK hynix is benefiting from sustained AI-driven memory demand, improving pricing, and constructive technicals. Recent headlines about a potential manufacturing tie-up with Intel and broader industry ordering strength argue the memory supercycle is not yet peaking. This is a tactical long trade with an entry at $185.00, stop at $170.00 and target at…

Vince (VNCE): Buy the Core Growth, Treat OVO as Optional Upside

Vince (VNCE): Buy the Core Growth, Treat OVO as Optional Upside

Vince has turned material operational progress into stronger cash generation and an earnings beat. At a market cap near $118M and EV/EBITDA of ~8.6x, the stock looks fairly valued to cheap given recent margin recovery and DTC momentum. I propose a mid‑term swing long with a clear entry, stop and target; treat any OVO-related upside as optional, not…

Pagaya (PGY): AI-Driven Funding Gains Momentum — A Mid-Stage Long Trade

Pagaya (PGY): AI-Driven Funding Gains Momentum — A Mid-Stage Long Trade

Pagaya has turned network growth into cash and profits: $1.3B revenue, positive free cash flow and accelerating ABS sales. The stock trades at a modest market cap of ~$1.72B and valuation multiples (P/S ~1.3x, EV/EBITDA ~7.3x) that look reasonable given 2H momentum. This trade targets a mid-term rebound as revenue and ABS issuance keep closing the …

Buy META Around the Muse Momentum — Monitor the AI Bill Closely

Buy META Around the Muse Momentum — Monitor the AI Bill Closely

Meta looks buyable into AI product momentum and continued ad recovery. The company's MTIA ASIC deployments and an expected Muse commercial push create high-reward catalysts over the next 45-180 trading days. That said, elevated RSI, a premium multiple and looming AI regulation mean this is a tactical buy with strict risk controls.

LuxExperience: Earnings Beat Turns My Old Thesis Into a Trade

LuxExperience: Earnings Beat Turns My Old Thesis Into a Trade

LuxExperience reported a revenue and EPS beat on 09/16/2026, pushing the stock above its moving averages and into bullish technical momentum. With a $1.30B market cap, PB below 1.0 and concentrated short positioning, this is a tactical long (swing) trade that balances upside to the $11 area against a controlled stop below $8.25. I lay out entry, ta…